MAX and adrenal gland pheochromocytoma: In all, 101 out of the 109 patients (92.7%) with MAX mutations developed PCC, of which bilateral PCC accounted for 58.4%, with a mean age at diagnosis of 31.7 ± 10.2 years (range, 14–55).